NCT00308178 - Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

June 30, 2008

Conditions

Breast Cancer

Interventions

DRUG

Abraxane

Following 4 cycles (8 weeks) of adjuvant chemotherapy (adriamycin and cytoxan), abraxane will be give every 2 weeks for 4 cycles(8 weeks)

Trial Locations (3)

Massacusetts General Hospital, Boston

Dana-Farber Cancer Institute, Boston

Beth Israel Deaconess Medical Center, Boston